Abstract
We investigated lipid composition and FA metabolism in Chinese hamster ovary (CHO-K1) cells and Pex5-mutated CHO-K1 (ZP102) cells to clarify the biochemical bases of peroxisome biogenesis disorders (PBD). ZP102 cells have defective peroxisomes and exhibit impairments of peroxisomal β-oxidation of FA and plasmalogen biosynthesis. In addition, we identified FA metabolic alterations in the synthesis of several classes of lipids in ZP102 cells. The concentration of FFA in ZP102 cells was twice that in CHO-K1 cells, but methyl esters and TAG were decreased in ZP102 cells in comparison with control cells. Also, ceramide monohexoside (CMH) concentration with ZP102 cells was significantly increased compared with the control cells. The FA molecular species, particularly the saturated to unsaturated ratios, of individual lipids also differed between the two cell types. The rate of incorporation of [14C]-labeled saturated acids into sphingomyelin (SM) and CMH in ZP102 cells was lugher than that in CHO-K1 cells. Lignoceric acid incorporated into cells was predominantly utilized for the synthesis of SM at 24 h after removal of [14C] lignoceric acid from the culture medium. ZP102 cells showed higher fluorescence anisotropy of 1,3,5-diphenylhexatriene, corresponding to lower membrane mobility than in CHO-K1 cells. In particular, alteration of lipid metabolism by a Pex5 mutation enhanced metabolism of saturated FA and sphingolipids. This may be related to the reduced membrane fluidity of ZP102 cells, which has been implicated in the dysfunction of membrane-linked processes in PBD.
Similar content being viewed by others
Abbreviations
- CE:
-
cholesterol ester(s)
- CHO-K1 cells:
-
Chinese hamster ovary K1 cells
- CMH:
-
ceramide monohexoside
- CNS:
-
central nervous system
- DHAP:
-
dihydroxyacetone phosphate
- DPH:
-
1,6-diphenyl-1,3,5-hexatriene
- GlcT:
-
ceramide glucosyltransferase
- PBD:
-
peroxisome biogenesis disorders
- PTS-1:
-
peroxisome targeting signal-1
- SM:
-
sphingomyelin
- VLCFA:
-
very long chain FA
- Z65 cells:
-
Pex2-mutated CHO-K1 cells
- ZP102 cells:
-
Pex5-mutated CHO-K1 cells
References
Gould, S.J., Raymond, G.V., and Valle, D. (2001) The Peroxisome Biogenesis Disorders, in The Metabolic and Molecular Bases of Inherited Disease (Scriver, B.V.S., Beaudet, V.S., Sly, W., Valle, D., Childs, B., Kinzler, K., and Vogelstein, B., eds.), pp. 3181–3217, McGraw-Hill, New York.
Moser, A.B., Kreiter, N., Bezman, L., Lu, S., Raymond, G.V., Naidu, S., and Moser, H.W. (1999) Plasma Very Long Chain Fatty Acids in 3,000 Peroxisome Disease Patients and 29,000 Controls, Ann. Neurol. 45, 100–110.
Powers, J.M., Tummons, R.C., Caviness, V.S., Jr., Moser, A.B., and Moser, H.W. (1989) Structural and Chemical Alterations in the Cerebral Maldevelopment of Fetal Cerebro-hepato-renal (Zellweger) Syndrome, J. Neuropathol. Exp. Neurol. 48, 270–289.
Baes, M., Gressens, P., Baumgart, E., Carmeliet, P. Casteels, M., Fransen, M., Evrard, P., Fahimi, D., Declercq, P.E., Collen, D., et al. (1997) A Mouse Model for Zellweger Syndrome, Nature Genet. 17, 49–57.
Faust, P.L., and Hatten, M.E. (1997) Targeted Deletion of the PEX2 Peroxisome Assembly Gene in Mice Provides a Model for Zellweger Syndrome, a Human Neuronal Migration Disorder, J. Cell Biol. 139, 1293–1305.
Huyghe, S., Casteels, M., Janssen, A., Meulders, L., Mannaerts, G.P., Declercq, P.E., van Veldhoven, P.P., and Baes, M. (2001) Prenatal and Postnatal Development of Peroxisomal Lipid-Metabolizing Pathways in the Mouse, Biochem. J. 353, 673–680.
Baes, M., Gressens, P., Huyghe, S., De N.K., Qi, C., Jia, Y., Mannaerts, G.P., Evrard, P., Van, V.P., Declercq, P.E., and Reddy, J.K. (2002) The Neuronal Migration Defect in Mice with Zellweger Syndrome (Pex5 knockout) Is Not Caused by the Inactivity of Peroxisomal β-Oxidation, J. Neuropathol. Exp. Neurol. 61, 368–374.
Tatsumi, K., Saito, M., Lin, B., Iwamori, M., Ichiseki, H., Shimozawa, N., Kamoshita, S., Igarashi, T., and Sakakihara, Y. (2001) Enhanced Expression of a-Series Gangliosides in Fibroblasts of Patients with Peroxisome Biogenesis Disorders, Biochim. Biophys. Acta 1535, 285–293.
Saito, M., Iwamori, M., Lin, B., Oka, A., Fujiki, Y., Shimozawa, N., Kamoshita, S., Yanagisawa, M., and Sakakihara, Y. (1999) Accumulation of Glycolipids in Mutant Chinese Hamster Ovary Cells (Z65) with Defective Peroxisomal Assembly and Comparison of the Metabolic Rate of Glycosphingolipids Between Z65 Cells and Wild-type CHO-K1 Cells, Biochim. Biophys. Acta 1438, 55–62.
Saito, M., Fukushima, Y., Tatsumi, K., Bei, L., Fujiki, Y., Iwamori, M., Igarashi, T., and Sakakihara, Y. (2002) Molecular Cloning of Chinese Hamster Ceramide Glucosyltransferase and Its Enhanced Expression in Peroxisome-Defective Mutant Z65 Cells, Arch. Biochem. Biophys. 403, 171–178.
Svennerholm, L., Rynmark, B.M., Vilbergsson, G., Fredman, P., Gottfries, J., Mansson, J.E., and Percy, A. (1991) Gangliosides in Human Fetal Brain, J. Neurochem. 56, 1763–1768.
Uemura, K., Sugiyama, E., and Taketomi, T. (1991) Effects of an Inhibitor of Glycosylceramide Synthase on Glycosphingolipid Synthesis and Neurite Outgrowth in Murine Neuroblastoma Cell Lines, J. Biochem. 110, 96–102.
Tettamanti, G., and Riboni, L. (1993), Gangliosides and Modulation of the Function of Neural Cells, Adv. Lipid Res. 25, 235–267.
Hannun, Y.A. (1996) Functions of Ceramide in Coordinating Cellular Responses to Stress, Science 274, 1855–1859.
Tsukamoto, T., Bogaki, A., Okumoto, K., Tateishi, K., Fujiki, Y., Shimozawa, N., Suzuki, Y., Kondo, N., and Osumi, T. (1997) Isolation of a New Peroxisome-Deficient CHO Cell Mutant Defective in Peroxisome Targeting Signal-1 Receptor, Biochem. Biophys. Res. Commun. 230, 402–406.
Dodt, G., Braverman, N., Wong, C., Moser, A., Moser, H.W., Watkins, P., Valle, D., and Gould, S.J. (1995) Mutations in the PTS1 Receptor Gene, PXR1, Define Complementation Group 2 of the Peroxisome Biogenesis Disorders, Nature Genet, 9, 115–125.
Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. (1951) Protein Measurement with the Folin Phenol Reagent, J. Biol. Chem. 193, 265–275.
Kawato, S., Jr., Kinosita, K., and Ikegami, A. (1977) Dynamic Structure of Lipid Bilayers Studied by Nanosecond Fluorescence Techniques, Biochemistry 16, 2319–2324.
Shinitzky, M., and Barenholz, Y. (1978) Fluidity Parameters of Lipid Regions Determined by Fluorescence Polarization, Biochim. Biophys. Acta 515, 367–394.
Lehner, R., and Kuksis, A. (1996) Biosynthesis of Triacylglycerols, Prog. Lipid Res. 35, 169–201.
Hajra, A.K., Larkins, L.K., Das, A.K., Hemati, N., Erickson, R.L., and MacDougald, O.A. (2000) Induction of the Peroxisomal Glycerolipid-Synthesizing Enzymes During Differentiation of 3T3-L1 Adipocytes. Role in Triacylglycerol Synthesis, J. Biol. Chem. 275, 9441–9446.
Rustan, A.C., Nossen, J.O., Christiansen, E.N., and Drevon, C.A. (1988) Eicosapentaenoic Acid Reduces Hepatic Synthesis and Secretion of Triacylclycerol by Decreasing the Activity of Acyl-Coenzyme A:1,2-Diacylglycerol Acyltransferase, J. Lipid Res. 29, 1417–1426.
Strum-Ordin, R.B., Adkins-Finke, W.L., Blake, W.L., Phinney, S.D., and Clarke, S.D. (1987) Modification of the Fatty Acid Composition of Membrane Phospholipids in Hepatocyte Monolayers with n−3, n−6, and n−9 Fatty Acids, Biochim. Biophys. Acta 921, 378–391.
Brown, F.R., III., Chen, W.W., Kirschner, D.A., Frayer, K.L., Powers, J.M., Moser, A.B., and Moser, H.W. (1983) Myelin Membranes from Adrenoleukodystrophy Brain White Matter—Biochemical Properties, J. Neurochem. 41, 341–348.
Knazek, R.A., Rizzo, W.B., Schulman, J.D., and Dave, J.R. (1983) Membrane Microviscosity Is Increased in the Erythrocytes of Patients with Adrenoleukodystrophy and Adrenomyeloneuropathy, J. Clin. Invest. 72, 245–248.
Whitcomb, R.W., Linehan, W.M., and Knazek, R.A. (1988) Effects of Long-Chain- Saturated Fatty Acids on Membrane Microviscosity and Adrenocorticotropin Responsiveness of Human Adrenocortical Cells in vitro. J. Clin. Invest. 81, 185–188.
Ho, J.K., Moser, H., Kishimoto, Y., and Hamilton, J.A. (1995) Interactions of a Very Long Cham Fatty Acid with Model Membranes and Serum Albumin. Implications for the Pathogenesis of Adrenoleukodystrophy, J. Clin. Invest. 96, 1455–1463.
Igal, R.A., Caviglia, J.M., de Gomez Dumm, I.N., and Coleman, R.A. (2000) Diacylglycerol Generated in CHO Cell Plasma Membrane by Phospholipase C Is Used for Triacylglycerol Synthesis, J. Lipid Res. 42, 88–95.
Igal, R.A., and Coleman, R.A. (1998) Neutral Lipid Storage Disease: A Genetic Disorder with Abnormalities in the Regulation of Phospholipid Metabolism, J. Lipid. Res. 39, 31–43.
Igal, R.A., and Coleman, R.A. (1998) Acylglycerol Recycling from Triacylglycerol to Phospholipid, Not Lipase Activity, Is Defective in Neutral Lipid Storage Disease Fibroblasts, J. Biol. Chem. 271, 16644–16651.
Ordway, R.W., Jr., Walsh, J.V., and Singer, J.J. (1989) Arachidonic Acid and Other Fatty Acids Directly Activate Potassium Channels in Smooth Muscle Cells, Science 244, 1176–1179.
Huang, J.M., Xian, H., and Bacaner, M. (1992) Long-Chain Fatty Acids Activate Calcium Channels in Ventricular Myocytes, Proc. Nat. Acad. Sci. USA 89, 6452–6456.
Nishizuka, Y. (1992) Intracellular Singaling by Hydrolysis of Phospholipids and Activation of Protein Kinase C, Science 258, 607–614.
Hamilton, J.A., Civelek, V.N., Kamp, F., Tornheim, K., and Corkey, B.E. (1994) Changes in Internal pH Caused by Movement of Fatty Acids into and out of Clonal Pancreatic β-Cells (HIT), J. Biol. Chem. 269, 20852–20856.
Hermetter, A., Rainer, B., Ivessa, E., Kalb, E., Loidl, J., Roscher, A., and Paltauf, F. (1989) Influence of Plasmalogen Deficiency on the Membrane Fluidity of Human Skin Fibroblasts: A Fluorescence Anisotrophy Study, Biochim. Biophys. Acta 978, 151–157.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Nagura, M., Saito, M., Iwamori, M. et al. Alterations of fatty acid metabolism and membrane fluidity in peroxisome-defective mutant ZP102 cells. Lipids 39, 43–50 (2004). https://doi.org/10.1007/s11745-004-1200-z
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11745-004-1200-z